|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 519/00 | (2006.01) |
| A61K 31/433 | (2006.01) | ||
| C07D 513/04 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/4355 | (2006.01) | ||
| A61P 7/02 | (2006.01) |
| (11) | Patento numeris | 3632919 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19192142.8 |
| Europos patento paraiškos padavimo data | 2013-04-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-26 |
| (46) | Apibrėžties vertimo paskelbimo data | 2023-02-27 |
| (30) | Numeris | Data | Šalis |
| 201261638577 P | 2012-04-26 | US | |
| 201361787680 P | 2013-03-15 | US |
| (72) |
BANVILLE, Jacques , CA
RÉMILLARD, Roger , CA
RUEDIGER, Edward H. , CA
DEON, Daniel H. , CA
GAGNON, Marc , CA
DUBÉ, Laurence , CA
GUY, Julia , CA
PRIESTLEY, Eldon Scott , US
POSY, Shoshana L. , US
MAXWELL, Brad D. , US
WONG, Pancras C. , US
LAWRENCE, Michael R. , US
MILLER, Michael M. , US
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
Université de Montréal , 2900 Boulevard Edouard-Montpetit, Montreal, QC H3T 1J4, CA |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazotiadiazolo ir imidazopirazino dariniai, kaip proteazės aktyvuoto receptoriaus 4 (PAR4) inhibitoriai, skirti trombocitų agregacijos gydymui |
| PHARMACEUTICAL COMPOISITIONS COMPRISING IMIDAZOTHIADIAZOLE AND IMIDAZOPYRIDAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2026-03-19 | 14 | 289.00 EUR |
| 2027-04-24 |